Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 2(7): e669, 2007 Aug 22.
Article in English | MEDLINE | ID: mdl-17712401

ABSTRACT

The HIV-1 nucleocapsid is formed during protease (PR)-directed viral maturation, and is transformed into pre-integration complexes following reverse transcription in the cytoplasm of the infected cell. Here, we report a detailed transmission electron microscopy analysis of the impact of HIV-1 PR and reverse transcriptase (RT) on nucleocapsid plasticity, using in vitro reconstitutions. After binding to nucleic acids, NCp15, a proteolytic intermediate of nucleocapsid protein (NC), was processed at its C-terminus by PR, yielding premature NC (NCp9) followed by mature NC (NCp7), through the consecutive removal of p6 and p1. This allowed NC co-aggregation with its single-stranded nucleic-acid substrate. Examination of these co-aggregates for the ability of RT to catalyse reverse transcription showed an effective synthesis of double-stranded DNA that, remarkably, escaped from the aggregates more efficiently with NCp7 than with NCp9. These data offer a compelling explanation for results from previous virological studies that focused on i) Gag processing leading to nucleocapsid condensation, and ii) the disappearance of NCp7 from the HIV-1 pre-integration complexes. We propose that HIV-1 PR and RT, by controlling the nucleocapsid architecture during the steps of condensation and dismantling, engage in a successive nucleoprotein-remodelling process that spatiotemporally coordinates the pre-integration steps of HIV-1. Finally we suggest that nucleoprotein remodelling mechanisms are common features developed by mobile genetic elements to ensure successful replication.


Subject(s)
HIV Protease/metabolism , HIV Reverse Transcriptase/metabolism , Nucleocapsid/ultrastructure , Binding Sites , DNA, Single-Stranded/chemistry , DNA, Single-Stranded/genetics , DNA, Viral/chemistry , DNA, Viral/genetics , Genome, Viral , HIV Protease/genetics , HIV Reverse Transcriptase/genetics , HIV-1/enzymology , HIV-1/genetics , Kinetics , Models, Molecular , Nucleocapsid/chemistry , RNA, Viral/chemistry , RNA, Viral/genetics
2.
J Mol Biol ; 364(3): 496-511, 2006 Dec 01.
Article in English | MEDLINE | ID: mdl-17020765

ABSTRACT

HIV-1 nucleocapsid protein (NCp7) condenses the viral RNA within the mature capsid. In a capsid-free system, NCp7 promotes an efficient mechanism of aggregation with both RNA and DNA. Here, we show an analysis of these macromolecular complexes by dark-field imaging using transmission electron microscopy. Thousands of mature NCp7 proteins co-aggregate with hundreds of single-stranded circular DNA molecules (ssDNA) within minutes, as observed with poly(rA). These co-aggregates are highly stable but dynamic structures, as they dissociate under harsh conditions, and after addition of potent ssDNA or NCp7 competitive ligands. The N-terminal domain and zinc fingers of NCp7 are both required for efficient association. Addition of magnesium slightly increases the avidity of NCp7 for ssDNA, while it strongly inhibits co-aggregation with relaxed circular double-stranded DNA (dsDNA). This DNA selectivity is restricted to mature NCp7, compared to its precursors NCp15 and NCp9. Moreover, for NCp15, the linkage of NCp7 with the Gag C-terminal p6-peptide provokes a deficiency in ssDNA aggregation, but results in DNA spreading similar to prototypical SSB proteins. Finally, this co-aggregation is discussed in a dynamic architectural context with regard to the mature HIV-1 nucleocapsid. On the basis of the present data, we propose that condensation of encapsidated RNA requires the C-terminal processing of NCp. Subsequently, disassembly of the nucleocapsid should be favoured once dsDNA is produced by HIV-1 reverse transcriptase.


Subject(s)
Capsid Proteins/chemistry , DNA, Single-Stranded/chemistry , DNA/chemistry , Gene Products, gag/chemistry , Magnesium/chemistry , Nucleocapsid Proteins/chemistry , Viral Proteins/chemistry , Capsid Proteins/genetics , Capsid Proteins/ultrastructure , DNA/ultrastructure , DNA, Single-Stranded/ultrastructure , Gene Products, gag/genetics , Gene Products, gag/ultrastructure , HIV-1/metabolism , Microscopy, Electron, Transmission , Nucleocapsid Proteins/genetics , Nucleocapsid Proteins/ultrastructure , Protein Structure, Tertiary , Viral Proteins/genetics , Viral Proteins/ultrastructure , gag Gene Products, Human Immunodeficiency Virus
3.
J Biol Chem ; 278(46): 45200-8, 2003 Nov 14.
Article in English | MEDLINE | ID: mdl-12944404

ABSTRACT

Globotriasosylceramide (Gb3), a neutral glycosphingolipid, is the B-cell differentiation antigen CD77 and acts as the receptor for most Shiga toxins, including verotoxin-1 (VT-1). We have shown that both anti-Gb3/CD77 mAb and VT-1 induce apoptosis in Burkitt's lymphoma cells. We compared the apoptotic pathways induced by these two molecules by selecting cell lines sensitive to only one of these inducers or to both. In all these cell lines (including the apoptosis-resistant line), VT-1 was transported to the endoplasmic reticulum and inhibited protein synthesis similarly, suggesting that VT-1-induced apoptosis is dissociated from these processes. VT-1 triggered a caspase- and mitochondria-dependent pathway (rapid activation of caspases 8 and 3 associated with a loss of mitochondrial membrane potential (Deltapsim) and the release of cytochrome c from mitochondria). In contrast, the anti-Gb3/CD77 mAb-induced pathway was caspase-independent and only involved partial depolarization of mitochondria. Antioxidant compounds had only marginal effects on VT-1-induced apoptosis but strongly protected cells from anti-Gb3/CD77 mAb-induced apoptosis. VT-1- and anti-Gb3/CD77 mAb-treated cells displayed very different features on electron microscopy. These results clearly indicate that the binding of different ligands to Gb3/CD77 triggers completely different apoptotic pathways.


Subject(s)
Apoptosis , Shiga Toxins/metabolism , Signal Transduction , Trihexosylceramides/metabolism , Antioxidants/metabolism , Antioxidants/pharmacology , Biological Transport , Blotting, Western , Burkitt Lymphoma/metabolism , Caspase 3 , Caspase 8 , Caspase 9 , Caspases/metabolism , Cell Death , Cell Line, Tumor , Cytosol/metabolism , Endoplasmic Reticulum/metabolism , Glycosylation , Humans , Ligands , Membrane Potentials , Microscopy, Electron , Time Factors , Transfection
4.
J Biol Chem ; 278(20): 18110-6, 2003 May 16.
Article in English | MEDLINE | ID: mdl-12639957

ABSTRACT

Viral protein R (Vpr) is a small protein of 96 amino acids that is conserved among the lentiviruses human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus. We recently sought to determine whether the karyophilic properties of Vpr, as well as its ability to bind nucleic acids, could be used to deliver DNA into cells. We have found that the C-terminal domain of Vpr-(52-96) is able to efficiently transfect various cell lines. Here, we show that the shortest active sequence for gene transfer corresponds to the domain that adopts a alpha-helix conformation. DNA binding studies and permeabilization assays performed on cells demonstrated that the peptides that are efficient in transfection condense plasmid DNA and are membranolytic. Electron microscopy studies and transfection experiments performed in the presence of inhibitors of the endocytic processes indicated that the major entry pathway of Vpr-DNA complexes is through endocytosis. Taken together, the results show that the cationic C-terminal alpha-helix of Vpr has DNA-condensing as well as membrane-destabilizing capabilities, both properties that are indispensable for efficient DNA transfection.


Subject(s)
Gene Products, vpr/chemistry , Cell Line , Cell Membrane/metabolism , Cells, Cultured , DNA/metabolism , Endocytosis , Erythrocytes/metabolism , Ethidium/pharmacology , Flow Cytometry , Gene Products, vpr/metabolism , Humans , Intercalating Agents/pharmacology , Microscopy, Electron , Nucleic Acids/chemistry , Peptides/chemistry , Peptides/pharmacology , Plasmids/metabolism , Polylysine/chemistry , Protein Binding , Protein Structure, Tertiary , Transfection , Transgenes
5.
Bioconjug Chem ; 13(1): 76-82, 2002.
Article in English | MEDLINE | ID: mdl-11792180

ABSTRACT

Polyplexes of high stability resulting from the condensation of a plasmid DNA by a cationic polymer are widely used to develop polymer-based gene delivery systems. However, the plasmid must be released from its vector once inside the cells for an efficient expression of the exogenous gene in the cell nucleus. We have designed a disulfide-containing cationic polymer termed poly[Lys-(AEDTP)] which allowed for the formation of polyplexes and the release of the plasmid in a reductive medium. The amino groups of polylysine were substituted with 3-(2-aminoethyldithio)propionyl residues in order to have each amino group of poly[Lys-(AEDTP)] interacting with a phosphate DNA linked to the polymer backbone via a disulfide bond. As evidenced by agarose gel electrophoresis and ethidium bromide/pDNA fluorescence restoration, poly[Lys-(AEDTP)] polyplexes were decondensed and the plasmid released upon treatment with either dithiothreitol, glutathione in the presence of glutathione reductase, or the thioredoxin reductase. Electron microscopy showed that polyplexes exhibiting spherical particles of a mean size at about 100 nm were decondensed in the presence of glutathione and exhibited filamentous aggregates. Finally, we found that the transfection of 293T7 and HepG2 cells was 10- and 50-fold more efficient with poly[Lys-(AEDTP)] polyplexes, respectively, than with poly[Lys] polyplexes. These results indicate that disulfide-containing cationic polymers must be borne in mind for developing polymer-base gene delivery systems.


Subject(s)
DNA/chemistry , Drug Carriers/chemistry , Polymers , Transfection/methods , Cations , Cell Line , DNA/genetics , Dithiothreitol/chemistry , Dithiothreitol/pharmacology , Electrochemistry , Fluorescent Dyes , Humans , Indicators and Reagents , Luciferases/genetics , Lysine/analogs & derivatives , Lysine/chemistry , Microscopy, Electron , Oxidation-Reduction , Plasmids/chemistry , Plasmids/genetics , Reducing Agents , Thioredoxins/chemistry , Thioredoxins/pharmacology
6.
Nucleic Acids Res ; 30(3): E12, 2002 Feb 01.
Article in English | MEDLINE | ID: mdl-11809900

ABSTRACT

Labeling of a covalently closed circular double-stranded DNA was achieved using a so-called 'padlock oligonucleotide'. The oligonucleotide was targeted to a sequence which is present in the replication origin of phage f1 and thus in numerous commonly used plasmids. After winding around the double-stranded target DNA sequence by ligand-induced triple helix formation, a biotinylated oligonucleotide was circularized using T4 DNA ligase and in this way became catenated to the plasmid. A gel shift assay was developed to measure the extent of plasmid modification by the padlock oligonucleotide. A similar assay showed that a modified supercoiled plasmid was capable of binding one streptavidin molecule thanks to the biotinylated oligonucleotide and that this binding was quantitative. The catenated complex was visualized by electron and atomic force microscopies using streptavidin conjugates or single strand-binding proteins as protein tags for the padlock oligonucleotide. This method provides a versatile tool for plasmid functionalization which offers new perspectives in the physical study of supercoiled DNA and in the development of improved vectors for gene therapy.


Subject(s)
DNA, Superhelical/chemistry , DNA, Superhelical/metabolism , Nucleic Acid Conformation , Oligonucleotides/chemistry , Oligonucleotides/metabolism , Base Sequence , Biotinylation , Coliphages/genetics , DNA/chemistry , DNA/genetics , DNA/metabolism , DNA/ultrastructure , DNA Ligases/metabolism , DNA, Superhelical/genetics , DNA, Superhelical/ultrastructure , Deoxyuracil Nucleotides/metabolism , Electrophoretic Mobility Shift Assay , Genetic Therapy/methods , Indicators and Reagents/metabolism , Microscopy, Atomic Force , Microscopy, Electron , Oligonucleotides/genetics , Plasmids/chemistry , Plasmids/genetics , Plasmids/metabolism , Plasmids/ultrastructure , Replication Origin/genetics , Streptavidin/metabolism , Substrate Specificity
7.
Somat Cell Mol Genet ; 27(1-6): 27-47, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12774939

ABSTRACT

Nucleic acid transfer in mammalian cels is drastically improved with devices which increase their delivery in the cytosol upon endocytosis. In this chapter, we describe the effect on plasmid DNA (pDNA) and oligonucleotide (ODN) transfer, of an histidine-rich peptide (H5WYG), histidylated oligolysine (HoK), and histidylated polylysine (HpK) designed on the basis of the membrane destabilization capacity of poly-L-histidine at a pH dose to that of the endosomes. We report that H5WYG, which permeabilizes the cell membrane at pH 6.4, favors the transfection mediated by lactosylated polylysine/pDNA complexes and, by lowering the pH of extracellular medium, allows the loading of the cytosol and the cell nucleus with ODN. We show that HoK forms small cationic spherical particles of 35 nm with ODN and HpK rod or toroid cationic particles of 100 nm with pDNA. PEGylation stabilizes these particles at physiological salt concentration. We also show that (i) HoK/ODN complexes yield a more than 20-fold increase of the biological activity of antisense ODN towards the inhibition of transient as well as constitutive gene expression and (ii) HpK/pDNA complexes yield a transfection efficiency of 3-4.5 order of magnitude higher than do polylysine/pDNA complexes. We also provide evidence that the effect of these polyhistidylated molecules is mediated by imidazole protonation in endosomes. Overall our data show that polyhistidylated molecules constitute interesting devices for an efficient cytosolic delivery of nucleic acids, and that ionic complexes between histidylated polylysine and a pDNA are attractive for developing a nonviral gene delivery system.


Subject(s)
Genetic Vectors/administration & dosage , Genetic Vectors/genetics , Histidine , Nucleic Acids/administration & dosage , Peptides/administration & dosage , Peptides/genetics , Amino Acid Sequence , Animals , Cell Membrane Permeability/drug effects , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Cytosol/drug effects , Cytosol/metabolism , Gene Transfer Techniques , Genetic Vectors/metabolism , Humans , Hydrogen-Ion Concentration , Imidazoles/chemistry , Molecular Sequence Data , Oligonucleotides/administration & dosage , Oligonucleotides/genetics , Peptides/metabolism , Polylysine/chemical synthesis , Polylysine/genetics , Protein Transport
SELECTION OF CITATIONS
SEARCH DETAIL
...